Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy

被引：12
作者：
Papic, Neven [1 ]
Maric, Lorna Stemberger [1 ,2 ]
Vince, Adriana [1 ,3 ]
机构：
[1] Univ Hosp Infect Dis, Zagreb, Croatia
[2] Univ Zagreb, Sch Dent Med, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
INFECTIOUS DISEASES | 2018年 / 50卷 / 06期
关键词：
RESISTANT ENTEROCOCCI; METRONIDAZOLE; EPIDEMIOLOGY; DISEASE; ADULTS;
D O I：
10.1080/23744235.2018.1425551
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：483 / 486
页数：4
相关论文
共 50 条
  • [1] Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents
    Van Hise, Nicholas W.
    Bryant, Alex M.
    Hennessey, Erin K.
    Crannage, Andrew J.
    Khoury, Jad A.
    Manian, Farrin A.
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (05) : 651 - 653
  • [2] Enhanced Efficacy of High Dose Oral Vancomycin Therapy in Clostridium difficile Diarrhea for Hospitalized Adults Not Responsive to Conventional Oral Vancomycin Therapy: Antibiotic Stewardship Implications
    Cunha, Burke A.
    Sessa, Julia
    Blum, Sharon
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (04)
  • [3] Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis
    Maraolo, Alberto Enrico
    Mazzitelli, Maria
    Zappulo, Emanuela
    Scotto, Riccardo
    Granata, Guido
    Andini, Roberto
    Durante-Mangoni, Emanuele
    Petrosillo, Nicola
    Gentile, Ivan
    ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [4] Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infection
    Brown, Chase C.
    Manis, Melanie M.
    Bohm, Nicole M.
    Curry, Scott R.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (04) : 396 - 401
  • [5] Long-Term Efficacy of Oral Vancomycin Prophylaxis for the Prevention of Clostridium difficile Recurrence
    Knight, Emmanuel M.
    Schiller, Daryl S.
    Fulman, Magda K.
    Rastogi, Rupangi
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (05) : 633 - 639
  • [6] Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection
    Hung, Yuan-Pin
    Lin, Hsiao-Ju
    Wu, Chi-Jung
    Chen, Po-Lin
    Lee, Jen-Chieh
    Liu, Hsiao-Chieh
    Wu, Yi-Hui
    Yeh, Fang Hao
    Tsai, Pei-Jane
    Ko, Wen-Chien
    ANAEROBE, 2014, 30 : 24 - 26
  • [7] Impact of Delayed Oral Vancomycin for Severe Clostridium difficile Infection
    Shah, Sunish
    Ereshefsky, Benjamin
    Pontiggia, Laura
    Cawley, Michael
    HOSPITAL PHARMACY, 2019, 54 (05) : 294 - 299
  • [8] Rethinking Strategies to Select Antibiotic Therapy in Clostridium difficile infection
    Chopra, Teena
    Goldstein, Ellie J. C.
    Gorbach, Sherwood L.
    PHARMACOTHERAPY, 2016, 36 (12): : 1281 - 1289
  • [9] Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection
    Stevens, Vanessa W.
    Nelson, Richard E.
    Schwab-Daugherty, Elyse M.
    Khader, Karim
    Jones, Makoto M.
    Brown, Kevin A.
    Greene, Tom
    Croft, Lindsay D.
    Neuhauser, Melinda
    Glassman, Peter
    Goetz, Matthew Bidwell
    Samore, Matthew H.
    Rubin, Michael A.
    JAMA INTERNAL MEDICINE, 2017, 177 (04) : 546 - 553
  • [10] Risk Factors for Systemic Vancomycin Exposure Following Administration of Oral Vancomycin for the Treatment of Clostridium difficile Infection
    Pettit, Natasha N.
    DePestel, Daryl D.
    Fohl, Alexander L.
    Eyler, Rachel
    Carver, Peggy L.
    PHARMACOTHERAPY, 2015, 35 (02): : 119 - 126
12345